Total RNA was isolated from corneal fibroblasts on a collagen vitrigel membrane with the use of a purification kit (RNeasy; Qiagen, Valencia, CA), and portions (0.5 μg) of the RNA were subjected to reverse transcription (RT) and polymerase chain reaction (PCR) analysis with an RT-PCR kit (One-Step; Invitrogen, Carlsbad, CA) based on the Taq system (Platinum; Invitrogen). The PCR protocol was designed to maintain amplification in the exponential phase. Sequences of the PCR primers (sense and antisense, respectively) were 5′-GGCGTTAAGGATCGGGTTAA-3′ and 5′-CGACGACCTGTACTTAGTGTCGGT-3′ for Cx43, 5′-TGCCATTACACGGTCCTCTG-3′ and 5′-GGTTCTGCCTCATCATTTCCTC-3′ for ZO-1, 5′-AGTGTGATAATAGTGAGTGCTATCC-3′ and 5′-TGTCATACCTGTCCATCTTTCTTC-3′ for occludin, 5′-TTCTCGCCTTCCTGGGATG-3′ and 5′-CTTGAACGATTCTATTGCCATACC-3′ for claudin, and 5′-ACCACAGTCCACGCCATCAC-3′ and 5′-TCCACCACCCTGTTGCTGTA-3′ for glyceraldehyde-3-phosphate dehydrogenase (G3PDH, internal control). RT and PCR incubations were performed with a PCR system (GeneAmp PCR System 2400-R; Perkin-Elmer, Foster, CA). RT was performed at 50°C for 30 minutes, and PCR was performed for 25 cycles, with each cycle consisting of incubations at 94°C for 2 minutes, 58°C for 30 seconds, and 72°C for 1 minute. The reaction mixture was then cooled to 4°C. Amplification products were fractionated by electrophoresis on a 1.5% agarose gel and were stained with ethidium bromide. For RT and real-time PCR analysis, total RNA was subjected to RT with a kit (Promega), and the resultant cDNA was subjected to real-time PCR analysis by rapid cycling in glass capillaries with the use of a thermocycler (Light-Cycler; Roche Molecular Biochemicals, Indianapolis, IN).